Neuropace, Inc. Common Stock

NPCENASDAQUSD
15.74 USD
0.58 (3.55%)AT CLOSE (11:59 AM EDT)
15.78
0.04 (0.22%)
POST MARKET (AS OF 07:40 PM EDT)
Post Market
AS OF 07:40 PM EDT
15.78
0.04 (0.22%)
🔴Market: CLOSED
Open?$16.30
High?$16.79
Low?$15.68
Prev. Close?$16.32
Volume?134.1K
Avg. Volume?200.9K
VWAP?$16.16
Rel. Volume?0.67x
Bid / Ask
Bid?$15.46 × 100
Ask?$16.85 × 100
Spread?$1.39
Midpoint?$16.16
Valuation & Ratios
Market Cap?536.6M
Shares Out?34.1M
Float?22.0M
Float %?66.1%
P/E Ratio?N/A
P/B Ratio?37.13
EPS?-$0.63
Dividend?0.00%
Ex-Dividend?N/A

Neuropace, Inc. Common Stock (NPCE) is currently trading at $15.74. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. NPCE is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Employees
220
Market Cap
556.4M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-04-22
Address
455 N. BERNARDO AVENUE
MOUNTAIN VIEW, CA 94043
Phone: (650) 237-2700
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
65
Short Sent.?
74
Piotroski F-Score?2/9Weak
Altman Z-Score?-2.65Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.79%Low
Short Interest?613.8K
Days to Cover?2.3
Free Float22.0M
Avg Daily Volume266.3K
Settlement Date2026-05-15
Financial Health
Current Ratio?5.38Strong
Quick Ratio?4.35Strong
Cash Ratio?0.91Adequate
Debt/Equity?4.08High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
3
37.13HIGH
P/S?
Peers
100
S&P
26
5.39FAIR
P/FCF?
N/A
EV/EBITDA?
S&P
97
-35.2CHEAP
EV/Sales?
Peers
100
S&P
29
5.84FAIR
Returns & Efficiency
ROE?
S&P
3
-149.2%WEAK
ROA?
S&P
3
-21.8%WEAK
Cash Flow & Enterprise
FCF?$-9836000
Enterprise Value?$580.9M
Fundamentals ratios updated end of day